|
|
Volumn 11, Issue 2, 2004, Pages 537-541
|
|
Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CONNEXIN 26;
DOXORUBICIN;
GAP JUNCTION PROTEIN;
PROTEIN BCL 2;
APOPTOSIS;
ARTICLE;
CELL DIVISION;
DRUG EFFECT;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETICS;
HUMAN;
MALE;
PHYSIOLOGY;
PROSTATE TUMOR;
TUMOR CELL LINE;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL DIVISION;
CELL LINE, TUMOR;
CONNEXINS;
DOXORUBICIN;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE THERAPY;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
MLCS;
MLOWN;
|
|
EID: 3242816322
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.11.2.537 Document Type: Article |
|
Times cited : (55)
|
|
References (0)
|
